Figure 4.
Schematic hypothesis of how abatacept reduces endothelial injury post-HSCT. Hypothesis of our proposed mechanism including neutrophil activation leading to production of NETs, activation of complement system, and endothelial injury, along with the possible role of abatacept in ameliorating these manifestations.